Actively Recruiting
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
Led by Centre Hospitalier le Mans · Updated on 2025-03-26
1380
Participants Needed
27
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Out-of-hospital cardiac arrest is a public health problem for which overall survival is below 10%. Post-cardiac arrest syndrome is the principal cause of death in intensive care units (ICU), due to refractory shock or brain injuries secondary to anoxia. Brain anoxia is responsible for severe neurological sequelae that may be aggravated by cerebral hypoperfusion during the first few hours after the return of spontaneous circulation. Current recommendations are to ensure that arterial blood pressure is sufficient for the perfusion of organs, but no minimum threshold mean arterial pressure (MAP) has been defined. In practice, most teams target a MAP of at least 65 mmHg. Several observational studies have shown a correlation between MAP and neurological prognosis, patients with a higher initial MAP having a better outcome. Recent pilot studies have demonstrated the feasibility of increasing the target MAP after cardiac arrest, but conflicting results have been obtained concerning patient prognosis. These findings may be explained by changes to the autoregulation of the brain after cardiac arrest, with a shift of the curve towards the right, or its abolition. Cerebral blood flow is dependent on MAP, and a target MAP of 65 mmHg for these patients may result in insufficient brain perfusion. Conversely, a too high MAP might cause brain lesions due to vasogenic edema, hemorrhagic complications or excess perfusion in conditions of diminished brain metabolism. An interventional study is required to evaluate the effect of increasing MAP on neurofunctional outcome after cardiac arrest. Given the data available for brain autoregulation, the correlation between MAP and prognosis, and the risks theoretically associated with a higher MAP, investigator plans to compare a standard threshold of MAP (≥ 65 mmHg) with a high threshold of MAP (≥ 90 mmHg). Investigator hypothesizes that a high MAP within the first 24 hours after cardiac arrest will improve neurofunctional outcome.
CONDITIONS
Official Title
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admission to ICU following an out-of-hospital cardiac arrest with an initially shockable or non-shockable rhythm
- Sustained return of spontaneous circulation (ROSC) defined as 20 minutes with signs of circulation without chest compressions
- Under invasive mechanical ventilation for coma, defined as a Glasgow score 64 8/15
- Consent from a relative or emergency inclusion procedure
You will not qualify if you...
- Age under 18 years
- In-hospital cardiac arrest (first cardiac arrest)
- Unwitnessed cardiac arrest with initial rhythm of asystole
- Delay between ROSC and randomization attempt greater than 6 hours
- Cardiac arrest due to multiple trauma
- Cardiac arrest due to hemorrhagic shock or severe hemorrhage requiring hemostasis
- Cardiac arrest secondary to acute brain disease (ischemic or hemorrhagic stroke, subarachnoid hemorrhage, severe traumatic brain injury)
- Refractory shock defined as MAP under 65 mmHg for more than one hour on norepinephrine or epinephrine over 1 bcg/kg/min despite fluids
- Extracorporeal circulatory support prior to inclusion
- Known allergy to norepinephrine or its excipients
- Decision to limit care before inclusion
- Modified Rankin score of 4 or 5 before cardiac arrest
- Inclusion in another interventional study focused on neurological prognosis
- Pregnancy or breastfeeding
- Adult patient deprived of freedom or under legal protection
- Non-French speaking
- Patient already included in this trial
- Absence of social security cover
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 27 locations
1
CHU Brest - Hôpital de La Cavale Blanche
Brest, France, 29609
Actively Recruiting
2
CH Brive
Brive-la-Gaillarde, France, 19100
Actively Recruiting
3
CHU Caen
Caen, France, 14000
Actively Recruiting
4
CH Cholet
Cholet, France, 49300
Actively Recruiting
5
CH Dieppe
Dieppe, France, 76200
Actively Recruiting
6
CHU Dijon - Hôpital F. Mitterrand
Dijon, France, 21079
Actively Recruiting
7
CHD Vendée
La Roche-sur-Yon, France, 85925
Actively Recruiting
8
CH Versailles
Le Chesnay, France, 78150
Not Yet Recruiting
9
Centre Hospitalier Du Mans
Le Mans, France, 72000
Actively Recruiting
10
CH Dr Schaffner
Lens, France, 62300
Actively Recruiting
11
CHU Lille
Lille, France, 59037
Actively Recruiting
12
CHU Limoges
Limoges, France, 87042
Actively Recruiting
13
APHM - Hôpital de la Timone
Marseille, France, 13005
Actively Recruiting
14
Hôpital Jacques Cartier
Massy, France, 91300
Not Yet Recruiting
15
CHU Nantes
Nantes, France, 44093
Not Yet Recruiting
16
CHU Nice - Hôpital Pasteur
Nice, France, 06001
Actively Recruiting
17
CHU Nice - Hôpital Archet
Nice, France, 06202
Actively Recruiting
18
CHU Nîmes
Nîmes, France, 30029
Actively Recruiting
19
CHR Orléans
Orléans, France, 45067
Not Yet Recruiting
20
Hôpital Cochin
Paris, France, 75014
Not Yet Recruiting
21
APHP - Hôpital Européen Georges Pompidou (HEGP)
Paris, France, 75015
Actively Recruiting
22
CHU Poitiers
Poitiers, France, 86021
Actively Recruiting
23
CHU Rennes
Rennes, France, 35000
Actively Recruiting
24
Centre Cardiologique du Nord
Saint-Denis, France, 93207
Actively Recruiting
25
CHRU Strasbourg - Nouvel Hôpital Civil
Strasbourg, France, 67091
Actively Recruiting
26
CHRU Tours - Hôpital Bretonneau
Tours, France, 37044
Actively Recruiting
27
CH Bretagne Atlantique
Vannes, France, 56000
Actively Recruiting
Research Team
C
Christelle JADEAU
CONTACT
N
Nicolas CHUDEAU
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here